Drug design via pharmacophore identification. Dopaminergic activity of 3H-benz[e]indol-8-amines and their mode of interaction with the dopamine receptor
- 1 May 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (5) , 648-654
- https://doi.org/10.1021/jm00155a011
Abstract
The design and synthesis of a series of 3H-benz(e)indol-8-amines are described. Two of the compounds are potent orally active dopaminergic agents as established by their ability to induce contralateral turning in rats with unilateral 6-hydroxydopamine-induced lesions of the nigrostriatal pathway, to induce ambulation in rats rendered akinetic by bilateral injections of 6-hydroxydopamine into the anterolateral hypothalamus, and to antagonize reserpine induced catalepsy in mice. The dopamine agonist activity of the 3H-benz(e)indol-8-amines establishes that a pyrrolo ring and a phenolic hydroxyl group can interact similarly with the dopamine receptor and provides evidence for the existence of a hydrogen-bond acceptor nucleus on the dopamine receptor macromolecule that is involved in the behaviored manifestations of dopamine agonists.This publication has 12 references indexed in Scilit:
- Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptorsJournal of Medicinal Chemistry, 1983
- FURTHER CHARACTERIZATION OF STRUCTURAL REQUIREMENTS FOR AGONISTS AT THE STRIATAL DOPAMINE D-1 RECEPTOR - STUDIES WITH A SERIES OF MONOHYDROXYAMINOTETRALINS ON DOPAMINE-SENSITIVE ADENYLATE-CYCLASE AND A COMPARISON WITH DOPAMINE RECEPTOR-BINDING1982
- ON THE STEREOCHEMISTRY OF DOPAMINERGIC ERGOLINE DERIVATIVES1981
- Neurochemical and Behavioral Evidence for a Selective Presynaptic Dopamine Receptor AgonistScience, 1980
- Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonistsJournal of Medicinal Chemistry, 1980
- Synthesis and pharmacology of 8-amino-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocine and related compoundsJournal of Medicinal Chemistry, 1980
- Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamolJournal of Medicinal Chemistry, 1979
- Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamolJournal of Medicinal Chemistry, 1979
- CONFORMATION OF DOPAMINE AT ITS RECEPTOR - BINDING OF MONOHYDROXY-2-AMINOTETRALIN ENANTIOMERS AND POSITIONAL ISOMERS1979
- Structural correlation between apomorphine and LSD: Involvement of dopamine as well as serotonin in the actions of hallucinogensJournal of Theoretical Biology, 1976